SEPTEMBER 25 DEADLINE: The Schall Law Firm Encourages Investors in Bausch Health Companies Inc. with Losses of $100,000 to Contact the FirmAccesswire • 09/18/23
SHAREHOLDER ALERT: The Law Offices of Vincent Wong Remind Bausch Investors of a Lead Plaintiff Deadline of September 25, 2023PRNewsWire • 09/18/23
Final Deadline Approaching for Bausch Health Companies Inc. Investors: Kessler Topaz Meltzer & Check, LLP Reminds Bausch Health Companies Inc. (BHC) Investors of September 25, 2023 Lead Plaintiff DeadlineBusiness Wire • 09/12/23
New Bausch Health Treatment PrUCERIS(R) (budesonide) Aerosol Foam Now Available Across Canada to Treat Mild to Moderate Distal Ulcerative Colitis in AdultsAccesswire • 09/12/23
Bausch + Lomb Launches MIEBO™ (Perfluorohexyloctane Ophthalmic Solution) in the United StatesBusiness Wire • 09/12/23
FINAL DEADLINE APPROACHING: The Schall Law Firm Encourages Investors in Bausch Health Companies Inc. with Losses of $100,000 to Contact the FirmAccesswire • 09/12/23
SHAREHOLDER ALERT: Potential Recovery for Bausch Health Companies Inc. (BHC) Investors Affected by Stock Drop – Levi & Korsinsky Pursuing Class Action LawsuitAccesswire • 09/11/23
SHAREHOLDER ALERT: Potential Recovery for Bausch Health Companies Inc. (BHC) Investors Affected by Stock Drop - Levi & Korsinsky Pursuing Class Action LawsuitAccesswire • 09/11/23
Bausch Health's Bausch + Lomb Announces Launch of Proposed Financing for Acquisition of XIIDRA(R)Accesswire • 09/11/23
Bausch + Lomb Announces Launch of Proposed Financing for Acquisition of XIIDRA®Business Wire • 09/11/23
Bausch Health Companies Inc. (BHC) Shareholder Reminder: Kessler Topaz Meltzer & Check, LLP Reminds BHC Investors of Securities Fraud Class Action Lawsuit Filed On Their BehalfPRNewsWire • 09/10/23
Bausch Health's Bausch + Lomb Announces Disclosure of Historical and Pro Forma Financial Information With Respect to Acquisition of XIIDRA(R)Accesswire • 09/06/23
Bausch + Lomb Announces Disclosure of Historical and Pro Forma Financial Information With Respect to Acquisition of XIIDRA®Business Wire • 09/06/23
Bausch + Lomb Will Present New Scientific Data on its Surgical Products and Pipeline at European Society of Cataract and Refractive Surgery Annual MeetingBusiness Wire • 09/06/23
ROSEN, A HIGHLY RECOGNIZED LAW FIRM, Encourages Bausch Health Companies Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - BHCPRNewsWire • 09/03/23
Kessler Topaz Meltzer & Check, LLP Reminds BHC Investors of September 25, 2023 Deadline in Securities Fraud Class Action against of Bausch Health Companies Inc. and Urges Investors with Substantial Losses to Contact the FirmPRNewsWire • 09/02/23
SHAREHOLDER ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of September 25, 2023 in the Class Action Filed on Behalf of Bausch Health Companies Inc.(BHC) ShareholdersPRNewsWire • 08/28/23
ROSEN, A HIGHLY RECOGNIZED LAW FIRM, Encourages Bausch Health Companies Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - BHCPRNewsWire • 08/25/23
DEADLINE ACTION ALERT: The Schall Law Firm Encourages Investors in Bausch Health Companies Inc. with Losses of $250,000 to Contact the FirmAccesswire • 08/25/23
Kessler Topaz Meltzer & Check, LLP Reminds Bausch Health Companies Inc. Investors of Important Deadline in Securities Fraud Class Action Lawsuit and Encourages Investors with Substantial Losses to Contact the FirmPRNewsWire • 08/24/23
Bausch + Lomb Announces Expiration of Hart-Scott-Rodino Waiting Period for Acquisition of XIIDRA®Business Wire • 08/24/23
INVESTOR ACTION ALERT: The Schall Law Firm Encourages Investors in Bausch Health Companies Inc. with Losses of $100,000 to Contact the FirmAccesswire • 08/19/23
BHC LAWSUIT: The Law Offices of Vincent Wong Notify Investors of a Class Action Lawsuit Involving Bausch Health Companies Inc.Accesswire • 08/18/23
